Guanfacine Extended Release Adjunctive to a Psychostimulant in the Treatment of Comorbid Oppositional Symptoms in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guanfacine Extended Release Adjunctive to a Psychostimulant in the Treatment of Comorbid Oppositional Symptoms in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Authors
Keywords
-
Journal
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Volume 24, Issue 5, Pages 245-252
Publisher
Mary Ann Liebert Inc
Online
2014-06-20
DOI
10.1089/cap.2013.0103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How Oppositionality, Inattention, and Hyperactivity Affect Response to Atomoxetine Versus Methylphenidate
- (2011) Gregory W. van Wyk et al. Journal of Attention Disorders
- A Comparison of Atomoxetine Administered as Once Versus Twice Daily Dosing on the School and Home Functioning of Children with Attention-Deficit/Hyperactivity Disorder
- (2011) James G. Waxmonsky et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany
- (2011) Ralf W. Dittmann et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder
- (2011) Timothy E. Wilens et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD
- (2011) S. H. Kollins et al. PEDIATRICS
- Methylphenidate Transdermal System in Adult ADHD and Impact on Emotional and Oppositional Symptoms
- (2010) Barrie K. Marchant et al. Journal of Attention Disorders
- Effects of Atomoxetine With and Without Behavior Therapy on the School and Home Functioning of Children With Attention-Deficit/Hyperactivity Disorder
- (2010) James G. Waxmonsky et al. JOURNAL OF CLINICAL PSYCHIATRY
- Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study
- (2009) Grazia Dell'Agnello et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
- (2009) Thomas J. Spencer et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
- (2009) Floyd R. Sallee et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
- (2009) Floyd R. Sallee et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
- (2008) J. Biederman et al. PEDIATRICS
- Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder
- (2008) M. E. Bangs et al. PEDIATRICS
- Effect of Lisdexamfetamine Dimesylate on Parent-Rated Measures in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis
- (2008) Frank A. Lopez et al. POSTGRADUATE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More